Clinical Trial

Prolongation of GLP-1 Adherence When Using Continuous Glucose Monitoring

Name: Prolongation of GLP-1 Adherence When Using Continuous Glucose Monitoring — clinical trial record (NCT06668935)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting

View on ClinicalTrials.gov →

Summary

This study is to see if the FreeStyle Libre 3 Continuous Glucose Monitoring System (FSL3) will help prolong the length of time people with diabetes maintain adherence to glucagon-like peptide 1 (GLP-1/GIP) agonists.

Protocol Amendment History 1 amendment

This ClinicalTrials.gov record has been amended once since 2024-10-30.

Trial Details

NCT Number	NCT06668935
Lead Sponsor	Abbott Diabetes Care
Conditions	Diabetes Mellitus
Enrollment	800 participants
Start Date	2024-10-24
Primary Completion	2026-10 (estimated)
Study Completion	2027-01 (estimated)
Updated on ClinicalTrials.gov	2025-01-15